Scynexis SCYX
NASDAQ SCYX
$4.91 -0.24 (-4.66%)
At close: Sep 9, 2026 · 4:00 PM EDT

Scynexis (SCYX) Retained Earnings (2013 - 2026)

Scynexis' (SCYX) quarterly Retained Earnings came in at $466.0 million in Q2 2026, up 7.55% on a YoY basis from $433.2 million in Q2 2025, and up 4.08% quarter-over-quarter from $447.7 million in Q1 2026.

Analysis

Scynexis (SCYX) Retained Earnings (2013 - 2026) Analysis & Trends

Scynexis (SCYX) has reported Retained Earnings for 14 consecutive years, with $466.0 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Retained Earnings rose 7.55% year-over-year to $466.0 million; the trailing twelve-month figure through Jun 2026 stood at $466.0 million (up 7.55% YoY), and the FY2025 full-year result was $434.5 million, up 0.68% from the prior year.
  • Retained Earnings improved to $466.0 million in Q2 2026 per SCYX's latest filing, from $447.7 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $466.0 million in Q2 2026 and bottomed at -$456.2 million in Q1 2023.
  • Historically, Retained Earnings has averaged $381.8 million across 5 years, with a median of $429.3 million in 2024.
  • The sharpest annual moves came in 2023 and 2024: Retained Earnings slumped 212.97% in 2023, then jumped 194.02% in 2024.
  • Over 5 years, Retained Earnings stood at $425.5 million in 2022, then advanced by 0.63% to $428.2 million in 2023, then grew by 0.79% to $431.6 million in 2024, then gained by 0.68% to $434.5 million in 2025, then climbed by 7.24% to $466.0 million in 2026.
  • According to Business Quant data, Retained Earnings over the past three periods registered $466.0 million, $447.7 million, and $434.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn -22.28 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 9.53 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 15.69 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 37.62 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn 558.00 Mn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn 5.10 Bn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn -6.33 Bn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn 20.97 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn 5.13 Bn
10 Scynexis 58.41 Mn -56.29 Mn - 465.97 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 465.97 Mn
Mar 31, 2026 447.69 Mn
Dec 31, 2025 434.52 Mn
Sep 30, 2025 433.79 Mn
Jun 30, 2025 433.24 Mn
Mar 31, 2025 432.42 Mn
Dec 31, 2024 431.57 Mn
Sep 30, 2024 430.59 Mn
Jun 30, 2024 429.66 Mn
Mar 31, 2024 428.90 Mn
Dec 31, 2023 428.17 Mn
Sep 30, 2023 427.61 Mn
Jun 30, 2023 426.94 Mn
Mar 31, 2023 -456.20 Mn
Dec 31, 2022 425.49 Mn
Sep 30, 2022 425.03 Mn
Jun 30, 2022 423.72 Mn
Mar 31, 2022 403.83 Mn
Dec 31, 2021 400.71 Mn
Sep 30, 2021 367.82 Mn